Virus News and Research

Latest Virus News and Research

Cancer-related care has decreased since the start of COVID-19

Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.

28 Jul 2020

Swiss study shows how critical time is in responding to COVID-19

A new study published on the preprint server medRxiv in July 2020 reveals the crucial nature of time as a factor in controlling the mortality rate in the current COVID-19 pandemic.

27 Jul 2020

Varying immune system responses can predict severe COVID-19 outcomes

The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale researchers published July 27 in the journal Nature.

27 Jul 2020

Ebola survivors have long-lasting severe immune dysfunction

In the 2013-2016 Ebola outbreak in West Africa, more than 28,000 people were infected, causing over 11,000 deaths.

27 Jul 2020

GW to participate in a clinical trial for investigational COVID-19 vaccine

The George Washington University today announced that it will participate in a clinical trial for an investigational COVID-19 vaccine.

27 Jul 2020

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.

27 Jul 2020

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.

27 Jul 2020

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

A vaccine candidate for preventing COVID-19 is advancing to a 30,000-participant phase 3 trial that begins today, and Brigham and Women's Hospital will play two key roles in the trial's next phase.

27 Jul 2020

Novel label-free imaging method can differentiate active T cells from those off duty

T cells are the immune soldiers at the frontlines of the battle with infiltrating pathogens that seek to cause disease. A new study published in Nature Biomedical Engineering describes a novel label-free imaging technique that can differentiate active T cells from those off duty.

27 Jul 2020

Alternative amplification technique could accelerate COVID-19 testing

An alternative amplification technique to detect SARS-CoV-2 RNA could offer a way to rapidly test large numbers of people for COVID-19, although the technique is not as sensitive as quantitative RT-PCR, the current standard method for COVID-19 testing.

27 Jul 2020

Flu vaccine may lower chances of getting Alzheimer's disease

People who received at least one flu vaccination were 17% less likely to get Alzheimer's disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston.

27 Jul 2020

College students more anxious, depressed during initial COVID-19 outbreak, study finds

College students were more anxious and depressed during the initial outbreak of COVID-19 than they were during similar time frames in previous academic years, according to a Dartmouth study.

27 Jul 2020

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announced the start of Phase II clinical trial for the treatment of newly diagnosed COVID-19 patients in collaboration with Yale University.

27 Jul 2020

EBV viral genome alters the host epigenetic landscape to drive stomach cancer

The Epstein-Barr virus (EBV), one of the most common human viruses, is associated with about 8-10 per cent of stomach -- or gastric -- cancers, the third leading cause of cancer death globally.

27 Jul 2020

Clinical trials of hydroxychloroquine in COVID-19 outpatients reported as safe

According to new research, the use of hydroxychloroquine among outpatients in clinical trials, without high-risk factors for cardiac arrhythmia, is safe.

27 Jul 2020

‘It’s about love and solidarity’: Mutual aid unites NYC neighbors facing COVID

Nancy Perez, a 45-year-old resident of the Brooklyn neighborhood of Bedford-Stuyvesant, contracted COVID-19 in March. She stayed quarantined in her room for a month to isolate from her two sons and grandson.

27 Jul 2020

Study provides new insights into the host cellular response to SARS-CoV-2 infection

The COVID-19 pandemic caused by the new coronavirus has created an unprecedented public health challenge globally. Little was known about how the infecting cells respond to the virus and how the virus hijacks the host cellular machinery.

27 Jul 2020

The color of COVID: Will vaccine trials reflect America’s diversity?

When U.S. scientists launch the first large-scale clinical trials for COVID-19 vaccines this summer, Antonio Cisneros wants to make sure people like him are included.

27 Jul 2020

High ACE2 Expression on pancreatic islet cells during inflammation could explain new-onset diabetes in COVID-19

A new study suggests that the SARS-CoV-2 infection may be linked to the onset of diabetes, via the infection of pancreatic islet beta cells, which produce insulin.

27 Jul 2020

Employers require COVID liability waivers as conflict mounts over workplace safety

After spending a May day preparing her classroom to reopen for preschoolers, Ana Aguilar was informed that the tots would not have to wear face masks when they came back. What's more, she had to sign a form agreeing not to sue the school if she caught COVID-19 or suffered any injury from it while working there.

27 Jul 2020

Virus News and Research

Latest Virus News and Research

Cancer-related care has decreased since the start of COVID-19

Swiss study shows how critical time is in responding to COVID-19

Varying immune system responses can predict severe COVID-19 outcomes

Ebola survivors have long-lasting severe immune dysfunction

GW to participate in a clinical trial for investigational COVID-19 vaccine

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Novel label-free imaging method can differentiate active T cells from those off duty

Alternative amplification technique could accelerate COVID-19 testing

Flu vaccine may lower chances of getting Alzheimer's disease

College students more anxious, depressed during initial COVID-19 outbreak, study finds

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

EBV viral genome alters the host epigenetic landscape to drive stomach cancer

Clinical trials of hydroxychloroquine in COVID-19 outpatients reported as safe

‘It’s about love and solidarity’: Mutual aid unites NYC neighbors facing COVID

Study provides new insights into the host cellular response to SARS-CoV-2 infection

The color of COVID: Will vaccine trials reflect America’s diversity?

High ACE2 Expression on pancreatic islet cells during inflammation could explain new-onset diabetes in COVID-19

Employers require COVID liability waivers as conflict mounts over workplace safety

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Virus News and Research

Latest Virus News and Research

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Newsletters you may be interested in